|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 138.5 SEK | -5.46% |
|
-5.07% | -24.11% |
| 04-15 | Gisli Hennermark to Leave His Position as CEO of Surgical Science Sweden AB | CI |
| 03-12 | Surgical Science Sweden to Step Down; Search for Successor Starts | MT |
Surgical Science Sweden AB (publ) reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported sales was SEK 250.11 million compared to SEK 197.69 million a year ago. Net income was SEK 116.52 million compared to SEK 66.89 million a year ago.
Basic earnings per share from continuing operations was SEK 2.29 compared to SEK 1.32 a year ago. Diluted earnings per share from continuing operations was SEK 2.29 compared to SEK 1.31 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -24.11% | 699M | |
| +9.17% | 33.88B | |
| +21.99% | 8.35B | |
| +31.37% | 4.24B | |
| -30.35% | 2.67B | |
| -19.21% | 1.45B | |
| -25.64% | 1.33B | |
| -33.21% | 1.16B | |
| +13.11% | 1B | |
| -34.50% | 892M |
SURGICAL SCIENCE SWEDEN AB 
